Company / Working Capital per Share
Inmune Bio, Inc. Working Capital per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.96
FY2025
5-year range
$0.86 / $5.80
FY2021-FY2025
Trend
+12.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share returned to growth in FY2025 after 3 years of decline, reaching $0.96.
Based on SEC 10-K filings.
0.96 in FY2025 with a 5-year CAGR of -14.1%.
Declined from $1.20 to $0.96 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -31.6%
- 5-Year CAGR
- -14.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital per share increased 12.0% year-over-year.
- Peak working capital per share was recorded in FY2021.
- Lowest working capital per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 49.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.96 | +12.0% |
| FY2024 | $0.86 | -28.1% |
| FY2023 | $1.20 | -60.3% |
| FY2022 | $3.01 | -48.1% |
| FY2021 | $5.80 | +181.5% |
| FY2020 | $2.06 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026